Elastography and Associated Imaging Techniques

This policy addresses elastography and related imaging (e.g., transient elastography/FibroScan, magnetic resonance elastography, multiparametric MRI) for noninvasive assessment and monitoring of liver fibrosis, primarily to stage advanced fibrosis and cirrhosis in chronic liver diseases such as hepatitis C and B, alcoholic liver disease, and NAFLD/NASH (including NAFLD patients with high‑risk features). Major limitations include that several elastography techniques and many indications are considered investigational or unproven, testing is limited by ascites, severe obesity, and acute hepatitis, and the policy is inactive and not to be used for current claims adjudication.

"Transient elastography (e."

Sign up to see full coverage criteria, indications, and limitations.